Dietary exposure assessment of cyadox based on tissue depletion of cyadox and its major metabolites in pigs,chickens, and carp

The tissue kinetics of cyadox, an antibacterial agent used in food animals, and its major metabolites in pigs, chickens, and carp were investigated followed by a complete dietary exposure assessment to evaluate the food safety of cyadox. Cyadox and its major metabolites, bisdeoxycyadox (Cy1), 4‐desoxycyadox (Cy2), N ‐(quinoxaline‐2‐methyl)‐cyanide acetyl hydrazine (Cy4), quinoxaline‐2‐carboxylic acid (Cy6), and 2‐hydromethyl‐3‐hydroxy‐quinoxaline (Cy12), were simultaneously quantitated with a high‐performance liquid chromatography?ultraviolet (HPLC ‐UV ) method. Pigs, chickens, and carp were fed with 150 mg/kg cyadox in feed for consecutive 60, 40, and 30 days, respectively. The residue amount of cyadox and its major metabolites in liver, kidney, muscle, and fat (skin) tissues was determined. Cy2 was below the limit of quantitation even at the withdrawal time of 6 hr, cyadox, Cy4, Cy6, and Cy12 could be detected at 6–24 hr with low level less than 50 μg/kg. By contrast, Cy1 persisted for 3 days in the kidney of pigs and chickens, and in the liver of carp. Based on these residue depletion data and previous toxicology results, the global estimated chronic dietary exposure assessment of cyadox for general population was conducted, indicating a zero withdrawal time (WDT ) may be appropriate for cyadox in food animals when used in feed for prolonged administration. These results provide analytical techniques and safety standards suitable for residue monitoring of cyadox in food animals.     

牛乳菌落总数测定的不确定度评定

对牛乳样品菌落总数的测定结果进行不确定度评定,为检测过程的质量控制提供科学依据.依据GB 4789.2—2016《食品安全国家标准食品微生物学检验菌落总数测定》检测牛乳样品的菌落总数,按照JJF 1059.1—2012《测量不确定度评定与表示》分析该检测结果不确定度的来源并建立数学模型,然后分别对引入的不确定度分量进行...     

The present and future of withdrawal period calculations for milk in the European Union: focus on heterogeneous,nonmonotonic data

Harmonization of the method for calculating the withdrawal period for milk dates from the 1990s. European harmonization has led to guidance with three accepted methods for determining the withdrawal period for milk that are currently applicable. These three methods can be used by marketing authorization holders, but, in some cases, their diversity can lead to very different withdrawal periods. This is particularly the case when concentrations in milk are nonmonotonic and heterogeneous, meaning that concentrations strictly increase and then strictly decrease with significant interindividual variability in the time to reach the maximal concentration. Here, we first describe the concepts associated with the different methods used in the harmonized approach currently applicable for the determination of milk withdrawal periods, and then, we propose the application of a modern pharmacometric tool. Finally, with a nonmonotonic heterogeneous dataset, we illustrate the usefulness of this tool in comparison with the three currently applicable methods and discuss the limitations and advantages of each method.     

Tissue residues of ractopamine and urinary excretion of ractopamine and metabolites in animals treated for 7 days with dietary ractopamine

Ractopamine HCl is a beta-adrenergic leanness-enhancing agent recently approved for use in swine. Depletion of ractopamine in tissues, and elimination of ractopamine and its metabolites in urine, is of interest for the detection of off-label use. The objectives of this study were to measure the residues of ractopamine in livers and kidneys of cattle (n = 6), sheep (n = 6), and ducks (n = 9) after treatment with dietary ractopamine for seven (sheep, ducks) or eight (cattle) consecutive days and to measure the depletion of ractopamine from urine of cattle and sheep. Two cattle and sheep and three ducks were each slaughtered with withdrawal periods of 0, 3, and 7 d. Urine samples were collected daily from cattle and sheep. Tissue ractopamine concentrations were determined using the regulatory method (FDA approved) for ractopamine in swine tissues. Ractopamine residues in urine samples were measured before and after hydrolysis of conjugates. Analysis was performed with HPLC using fluorescence detection after liquid- (hydrolyzed samples) and(or) solid-phase extraction. No residues were detected in duck tissues. Liver residues in sheep averaged 24.0 and 2.6 ppb after 0- and 3-d withdrawal periods, respectively. Sheep liver residues after a 7-d withdrawal period were less than the limit of quantification (2.5 ppb). Sheep kidney residues were 65.1 and undetectable at 0- and at 3- and 7-d, withdrawal periods, respectively. Cattle liver residues were 9.3, 2.5, and undetectable after 0-, 3-, and 7-d withdrawal periods, respectively; kidney residues were 97.5, 3.4, and undetectable at the same respective withdrawal periods. Concentrations of parent ractopamine in sheep urine were 9.8+/-3.3 ppb on withdrawal d 0 and were below the LOQ (5 ppb) beyond the 2-d withdrawal period. After the hydrolysis of conjugates, ractopamine concentrations were 5,272+/-1,361 ppb on withdrawal d 0 and 178+/-78 ppb on withdrawal d 7. Ractopamine concentrations in cattle urine ranged from 164+/-61.7 ng/mL (withdrawal d 0) to below the LOQ (50 ppb) on withdrawal d 4. After the hydrolysis of conjugates in cattle urine, ractopamine concentrations were 4,129+/-2,351 ppb (withdrawal d 0) to below the LOQ (withdrawal d 6). These data indicate that after the hydrolysis of conjugates, ractopamine should be detectable in urine of sheep as long as 7 d after the last exposure to ractopamine and as long as 5 d after withdrawal in cattle.     

超高效液相色谱-串联质谱法测定牛奶中的赛拉嗪残留

采用乙腈提取,HLB固相萃取柱净化、超高效液相色谱-串联质谱测定,建立了一种简单、快速的牛奶中赛拉嗪残留的检测方法.对样品的提取、净化过程进行了优化改进,经ACQUITY UPLCTM BEH C18色谱柱分离,正离子电喷雾电离串联质谱测定,牛奶中赛拉嗪的检测限为0.2 μg/kg,定量限为0.5μg/kg.选取0.5...     

QuEChERS-超高效液相色谱-串联质谱法测定牛乳中6种农药残留

建立超高效液相色谱-串联质谱法检测牛乳中6种农药残留量的方法.用乙腈对牛乳进行提取,应用QuEChERS方法进行净化处理,氮吹后复溶,采用C18色谱柱梯度洗脱方式进行液相色谱分离,乙腈和体积分数0.1％甲酸-水溶液为流动相,采用电喷雾离子源正离子模式、多反应监测模式进行检测,外标法定量.结果表明:在1.0～40.0μg...     

猪肾脏等组织中盐酸莱克多巴胺的HPLC检测方法及其残留消除

本研究建立了猪肝脏、肾脏、肌肉和脂肪中盐酸莱克多巴胺的高效液相色谱检测方法。方法的检测限为1ng/g,定量限为2 ng/g,肝脏的平均回收率在73.4%～83.2%,变异系数在2.1%～6.6%;肾脏的平均回收率在73.1%～95.5%,变异系数在3.8%～4.0%;肌肉的平均回收率在80.7%～82.5%,变异系数在4.9%～9.1%;脂肪的平均回收率在73.3%～78.8%,变异系数在2.9%～6.7%。对60头健康猪以18 mg/kg的剂量混饲给药28d,停药饲喂14 d。在给药7、142、8 d和停药1、2、3、7、9、14 d分别屠宰6头猪,取各组织进行残留量测定。结果显示：肾脏中残留量最高,肝脏其次,残留量在停药期间较给药期间显著降低。其中肾脏和肝脏中的残留量分别在停药14 d、停药9 d后降至定量限以下;肌肉和脂肪中的残留量显著低于肾脏和肝脏,给药28 d时,残留基本低于定量限;停药1 d时均低至检测限以下。     

Closantel plasma and milk disposition in dairy goats: assessment of drug residues in cheese and ricotta

Closantel (CLS) is currently used in programs for the strategic control of gastrointestinal nematodes. CLS is extralabel used in different dairy goat production systems. From available data in dairy cows, it can be concluded that residues of CLS persist in milk. The current work evaluated the concentration profiles of CLS in plasma and milk from lactating orally treated dairy goats to assess the residues pattern in dairy products such as cheese and ricotta. Six (6) female Saanen dairy goats were treated orally with CLS administered at 10 mg/kg. Blood and milk samples were collected between 0 and 36 days post‐treatment. The whole milk production was collected at 1, 4, 7, and 10 days post‐treatment to produce soft cheese and ricotta. CLS concentrations in plasma, milk, cheese, whey, and ricotta were determined by HPLC. The concentrations of CLS measured in plasma were higher than those measured in milk at all sampling times. However, the calculated withdrawal time for CLS in milk was between 39 and 43 days postadministration to dairy goats. CLS residual concentrations in cheese (between 0.93 and 1.8 μg/g) were higher than those measured in the milk used for its production. CLS concentrations in ricotta were sixfold higher than those in the milk and 20‐fold higher than those in the whey used for its production. The persistent and high residual concentrations of CLS in the milk and in the cheese and ricotta should be seriously considered before issuing any recommendation on the extralabel use of CLS in dairy goat farms.     

Kinetics and residues after intraperitoneal procaine penicillin G administration in lactating dairy cows

This paper describes the pharmacokinetic profile of procaine penicillin G after intraperitoneal (IP) administration in eight lactating dairy cows. Procaine pencillin G (PPG, 21 000 IU/kg) was deposited into the abdominal cavity of each cow following an incision in the right paralumbar fossa. Blood and milk samples were taken over the following 10 days, at which point the cows were euthanized. Plasma, milk, muscle, liver, and kidney penicillin concentrations were determined by HPLC, with a limit of quantification of 5 ng/mL for plasma and milk and 40 ng/g for tissue samples. A noncompartmental method was used to analyze plasma kinetics. The mean pharmacokinetic parameters (±SD) were: C _max, 5.5 ± 2.6 μg/mL; T _max, 0.75 ± 0.27 h; AUC _0-∞, 10.8 ± 4.9 μg·h/mL; MRT , 2.2 ± 0.9 h. All milk from treated cows contained detectable penicillin residues for a minimum of three milkings (31 h) and maximum of five milkings (52 h) after administration. Concentrations of penicillin in all muscle, liver, and kidney samples taken 10 days postadministration were below the limit of quantification. Necropsy examinations revealed foci of hemorrhage on the rumenal omentum of most cows but peritonitis was not observed. Systemic inflammation as determined by change in leukogram or plasma fibrinogen was noted in one cow. The results of this study demonstrate that IP PPG is absorbed and eliminated rapidly in lactating dairy cows.     

Critical review on the withdrawal period calculation for injection site residues

This review concerns a statistical method for calculating withdrawal period for injection site residues. A recently adopted Committee for Medicinal Products for Veterinary Use/European Agency for the Evaluation of Medicinal Product (CVMP/EMEA) guideline recommends to apply the same method for the calculation of withdrawal period for injection site residues as for other edible tissues. For reasons in this study developed below, this approach is deemed to be inappropriate for the injection site residues. The injection site residues often violate regression assumptions with regard to homoscedasticity (same variance in residue concentrations for different slaughter times) and linearity (of the mean depletion curve in log(e)-scale). The currently recommended method cannot adequately handle these aspects. An alternative pragmatic method taking into account the last slaughter time with all data below the reference threshold, combined with a safety span, is proposed for injection site residues. A nonparametric approach for calculating the withdrawal period is also presumed to be a sound alternative. The references commonly used are the Maximum Residue Limit (MRL) and the Acceptable Daily Intake (ADI). Unfortunately these references are not relevant to the acute risk exposure associated with injection site consumption. The use of alternative references, such as the Acceptable Single Dose Intake (ASDI) or the Acute Reference Dose (ARD) are thought to be more appropriate.     

A rapid analytical method of major milk proteins by reversed‐phase high‐performance liquid chromatography

A reversed‐phase high‐performance liquid chromatography (RP‐HPLC) method with rapid and automated analysis, good separation, high resolution, high accuracy and reproducible results was successfully developed and used to separate and quantify the major cow milk proteins within 30 min analytical time. Standard solutions of single purified cow milk proteins were used to develop calibration equations. The RP‐HPLC method was validated with respect to intra‐day repeatability, inter‐day precision, linearity, accuracy and limit of detection (LOD). The recoveries of the RP‐HPLC analyses of major milk proteins from cows ranged 71.0–114%, the inter‐day precision was expressed as the relative standard deviation, and the ranged from 1.51 to 4.60% and the LOD ranged from 0.08 g/L to 0.28 g/L. Major proteins in cow were quantified according to the chromatographic profiles. Results showed that a rapid RP‐HPLC method for quantifying the major cow milk proteins was developed, which could be used to determine milk protein contents in the dairy industry.     

牦牛主要寄生虫病高效低残留防治技术研究(中)

为制定埃普利诺菌素(EPR)休药期及建立牦牛主要寄生虫病高效低残留防治技术提供科学依据。采用荧光高效液相色谱法(HPLC-FLD)检测埃普利诺菌素(EPR)注射剂在牦牛奶中的残留消除规律。结果表明:给泌乳牦牛皮下注射EPR注射液0.2mg·kg^-1剂量,EPR在牛奶中分布浓度较低,在给药后54.00h,牛奶中的EPR浓度达到峰值7.38±2.61ng·mL^-1,该值低于美国规定的EPR在牛奶中的最高残留限量(12ng·mL^-1)和欧盟及联合国粮食与农业组织(FAO)规定的EPR在牛奶中的最高残留限量(20ng·mL^-1)。给泌乳牦牛皮下注射EPR注射液0.4mg·kg^-1剂量,EPR在牛奶中分布浓度较低,在给药后42.00 h,牛奶中的EPR浓度达到峰值8.42±4.62 ng·mL^-1,最高值低于欧盟和联合国粮食与农业组织(FAO)规定的EPR在牛奶中的最高残留限量(20 ng·mL^-1),略高于美国规定的EPR在牛奶中的最高残留限量(12ng·mL^-1);在给药后56.00 h,牛奶中的EPR浓度达到峰值6.98±2.98 ng·mL^-1,该值低于美国规定的EPR在牛奶中的最高残留限量(12ng·mL^-1)和欧盟及联合国粮食与农业组织(FAO)规定的EPR在牛奶中的最高残留限量(20ng·mL^-1)。国产药物试验组与进口商品化制剂对照组的两种EPR浇泼剂在牦牛血浆中的残留消除规律,分别于1.67±0.2d与1.83±0.61d(Tmax)在血浆中达到最高药物浓度(Cmax)7.88±2.68ng·mL^-1与5.94±2.80ng·mL^-1,两种EPR制剂的生物等效性无显著性差异。国产和进口两种制剂的残留均低于联合国粮食与农业组织(FAO)所规定的最高残留限量(20ng·mL^-1)。研究结果表明,EPR注射剂0.2mg·kg^-1、0.4mg·kg^-1,EPR浇泼剂0.5mg·kg^-1推荐剂量用于泌乳牦牛无需弃奶期,牦牛乳用时无需休药期或建议休药期为1d。为建立牦牛主要寄生虫病高效低残留防治技术提供了依据。     

乳房炎牛奶中复方阿莫西林纳米乳的残留检测及消除试验

利用高效液相色谱仪建立复方阿莫西林纳米乳（AMX-LH-NE）在牛奶中的残留监控高效液相色谱法（HPLC）,并通过残留消除试验,研究AMX-LH-NE在乳房炎牛奶中的残留消除规律,确定其弃奶期。结果显示,阿莫西林（AMX）和盐酸左氧氟沙星（LH）分别在7.5～400μg/L和40～600μg/L线性关系良好;平均回收率为（99.72±1.46）%和（99.65±1.53）%;相对标准偏差（relative standard deviation,RSD）为1.46%和1.54%;平均保留时间为（11.59±0.21）min和（6.87±0.02）min;日内精密度RSD为1.59%和1.39%,日间精密度RSD为3.17%和3.29%。在乳房炎牛奶中,AMX和LH的残留量均随着休药时间的延长而迅速降低;AMX的弃奶期为停药后35.96h,LH的弃奶期为停药后32.94h。结果表明,所建立的HPLC方法专属性好,回收率、重复性和精密度高,可为牛奶中AMX-LH-NE的残留监控提供检测方法;利用此检测方法确定的AMX-LH-NE的弃奶期为停药后36h。     

Comparison between stearoyl‐CoA desaturase expression in milk somatic cells and in mammary tissue of lactating dairy cows

Stearoyl‐CoA desaturase (SCD) is an important enzyme in the bovine mammary gland, where it inserts a cis‐double bond at the Δ9 position in a wide range of fatty acids. Investigating SCD expression in the bovine mammary gland generally requires invasive biopsy to obtain mammary tissue. The aim of this study was to evaluate the use of milk somatic cells as a non‐invasive alternative to biopsy for measuring mammary SCD expression in dairy cows. Both milk somatic cells and mammary tissue were collected from 14 Holstein‐Friesian cows and used for analysis of SCD expression by real‐time PCR. The SCD5 mRNA levels in mammary tissue compared with SCD1 were low, and for several milk somatic cell samples, SCD5 expression was even below the limit of detection. A significant relationship was found between SCD1 expression in milk somatic cells and in mammary tissue. In addition, SCD1 expression in milk somatic cells was significantly related to Δ9‐desaturase indices in milk, which are commonly used as an indicator of SCD1 activity within the mammary gland. Our study showed that milk somatic cells can be used as a source of mRNA to study SCD1 expression in dairy cows, offering a non‐invasive alternative to mammary tissue samples obtained by biopsy.     

Depletion of florfenicol in lactating dairy cows after intramammary and subcutaneous administration

Eighteen Holstein dairy cows ranging in body weight from 500–700 kg and with an average milk yield of 37 ± 6 kg/day were used to investigate the depletion of florfenicol (FFL) in milk and plasma of dairy cows. Three groups of six were administered FFL: Group A, intramammary (IMM) infusion of ~2.5 mg FFL/kg BW at three consecutive milking intervals (total amount of ~7.5 mg/kg BW); Group B, one IMM infusion (20 mg/kg BW) into one quarter and Group C, one subcutaneous (SC) treatment (40 mg/kg BW). IMM infusions were into the right front quarter. Cows were milked daily at 06:00 and 18:00 h. The highest concentrations (C_max) and time to C_max (T_max) were: 1.6 ± 2.2 μg·FFL/mL milk at 22 h (Group A), 5.5 ± 3.6 μg·FFL/mL milk at 12 h (Group B), and 1.7 ± 0.4 μg·FFL/mL milk at 12 h (Group C). The half‐lives (t_1/2) were ~19, 5.5, and 60 h, for Groups A, B, and C, respectively. FFL was below the limit of detection (LOD) by 60 h in three Group B cows, but above the LOD at 72, 84, and 120 h in three cows. FFL was above the LOD in milk from Group C's cows for 432–588 h. Plasma values followed the same trends as milk. The results demonstrate that IMM‐infused FFL is bioavailable and below the LOD within 72–120 h. The concentration of FFL was detectable in both plasma and milk over the course of 2–3 weeks after SC administration. The absence of residue depletion data presents problems in determining safe levels of FFL residues in milk and edible tissues. The data presented here must not be construed as approval for extra‐label use in food animals.     

Evaluation of the potential effects of abortion on the productive performance of Iranian Holstein dairy cows

Calving records from the Animal Breeding Center of Iran collected from January 1983 to December 2007 and comprising 1 163 594 Holstein calving events from 2552 herds were used to evaluate the potential effect of abortion occurrence on 305‐day milk yield, milk fat yield, fat percentage of milk and milk protein yield in Iranian Holsteins. Statistical analyses of production traits were performed using a linear mixed model procedure. Normal‐calved cows had greater 305‐day milk production, fat yield and protein yield of milk than abortive‐calved cows (P < 0.05). However, abortive‐calved cows had the greater milk fat percentage than normal calved cows (P < 0.05). The linear and quadratic effects of age of dam were significant on all of the studied traits (P < 0.05). The results of regression analysis showed that increase in the quadratic effect of age can cause an increase in the fat percentage of milk for all calvings including normal and abortive calvings. Because abortion is one of the most important conditions that limit a cow's ability to produce, maintaining the general health of cattle is important in minimizing the risk of abortion problems.     

Withdrawal time estimation of veterinary drugs: extending the range of statistical methods

In order to use a drug in a food producing animal, evidence has to be provided that after a certain withdrawal time, drug residues in tissues, such as muscle meat, fat, liver, kidney etc., are below a given maximum residue limit (MRL), for a majority of animals. Several statistical methods, both regression based and nonparametric based methods, have been proposed, each relying on different sets of assumptions, which may or may not hold for the specific data situation. The purpose of this paper is to enrich the range of methods, i.e. to provide approaches for situations where current methods are inappropriate. Bayesian methods, using Markov chain Monte Carlo, are proposed to derive inference on the parameters of interest.     

Determination of cloxacillin residues in dairy cows after intramammary administration

The aim of this study was to perform a comparative analysis of the characteristics of cloxacillin (CLO) (MRL of withdrawal in bovine milk is 30 ng/g) after a single intramammary (IMM) dose in the dry period (DP) and lactation (LP), and to establish a high‐performance liquid chromatography (HPLC) analytical method for CLO detection in milk. The research was conducted on a group of 10 cows in DP and 10 in LP. A single dose of 600 mg of CLO was administrated by the IMM route for a single quarter in DP and 500 mg for a single quarter in LP. CLO concentration was analyzed by HPLC. CLO was monitored at a wavelength of 206 nm. Pharmacokinetic calculations were performed using Phoenix^® WinNonlin^® 6.4 software. The calibration curve was linear over the range of 13.03–28 019.00 ng/g with the coefficient of determination R² > 0.999. CLO withdrawal in both the LP and DP group had a biphasic nature. The total CLO elimination in the DP and LP group was reached after 36 and 6.5 days, respectively. A quantitative and confirmatory method for the determination of CLO in fresh milk has been established. We have confirmed that the withdrawal of CLO in the DP group is not a linear process and has a stepwise character.     

Use of population pharmacokinetic modeling and Monte Carlo simulation to capture individual animal variability in the prediction of flunixin withdrawal times in cattle

The objective of this study was to develop a population pharmacokinetic (PK) model and predict tissue residues and the withdrawal interval (WDI) of flunixin in cattle. Data were pooled from published PK studies in which flunixin was administered through various dosage regimens to diverse populations of cattle. A set of liver data used to establish the regulatory label withdrawal time (WDT) also were used in this study. Compartmental models with first‐order absorption and elimination were fitted to plasma and liver concentrations by a population PK modeling approach. Monte Carlo simulations were performed with the population mean and variabilities of PK parameters to predict liver concentrations of flunixin. The PK of flunixin was described best by a 3‐compartment model with an extra liver compartment. The WDI estimated in this study with liver data only was the same as the label WDT. However, a longer WDI was estimated when both plasma and liver data were included in the population PK model. This study questions the use of small groups of healthy animals to determine WDTs for drugs intended for administration to large diverse populations. This may warrant a reevaluation of the current procedure for establishing WDT to prevent violative residues of flunixin.     

Estimation of breeding values from large‐sized routine carcass data in Japanese Black cattle using Bayesian analysis

Volumes of official data sets have been increasing rapidly in the genetic evaluation using the Japanese Black routine carcass field data. Therefore, an alternative approach with smaller memory requirement to the current one using the restricted maximum likelihood (REML) and the empirical best linear unbiased prediction (EBLUP) is desired. This study applied a Bayesian analysis using Gibbs sampling (GS) to a large data set of the routine carcass field data and practically verified its validity in the estimation of breeding values. A Bayesian analysis like REML‐EBLUP was implemented, and the posterior means were calculated using every 10th sample from 90 000 of samples after 10 000 samples discarded. Moment and rank correlations between breeding values estimated by GS and REML‐EBLUP were very close to one, and the linear regression coefficients and the intercepts of the GS on the REML‐EBLUP estimates were substantially one and zero, respectively, showing a very good agreement between breeding value estimation by the current GS and the REML‐EBLUP. The current GS required only one‐sixth of the memory space with REML‐EBLUP. It is confirmed that the current GS approach with relatively small memory requirement is valid as a genetic evaluation procedure using large routine carcass data.